Alipay Aims to Help 10 Million European Merchants Reach Over 2 Billion Potential Consumers in Five Years With Innovative Technology
14.11.2019 14:08:00 EET | Business Wire | Press release
Alipay, the world’s leading payment and lifestyle platform, today announced a new target to support 10 million small and medium enterprises in Europe over the next five years, through innovative technology that will empower these merchants to better serve and sell to over 2 billion potential consumers travelling to the region from around the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005332/en/
A Chinese tourist uses Alipay to pay for items at a store in Norway. (Photo: Business Wire)
The strategy to support these merchants was unveiled today during the Alipay Partners Global Summit held in London. This includes an expanded collaboration with the largest European acquirer Worldline, as well as a new initiative to serve airport shops around the world through in-app mini programs.
“Our aim is to improve the way in which individuals and businesses buy, sell and receive payments, and to do this, we need to draw upon the strength of our partnerships,” said Eric Jing, Chairman and CEO of Ant Financial, operator of Alipay. “Our growth has only been possible due to the network of partners we have established, and working together, we will make it easier for anyone to do business anywhere.”
“Our innovative solutions will continue to help merchants in Europe better serve the growing numbers of tourists as well as e-commerce shoppers coming to the region from all over the world,” Eric said.
Alipay is China's most popular digital payment service, according to market researcher Statista, with 87 percent of survey respondents in the country aged between 18 and 69 reporting that they use Alipay for their digital financial needs. Alipay currently serves over 1.2 billion users together with local e-wallet partners in the Republic of Korea, Thailand, Malaysia, the Philippines, Indonesia, India, Bangladesh, and Pakistan.
Alipay is continually working with its partners around the world, leveraging technology to build a seamless ecosystem that allows merchants to better serve their customers, which will in return help boost their sales.
In a report published this year, Nielsen found that over 93% of Chinese tourists would be more willing to make purchases with their mobile phones and would even increase their spending if the option were available, while 60% of merchants surveyed that adopted Alipay reported growth in foot traffic and revenue.
Currently, Alipay collaborates with more than 120 financial institutions in Europe and is constantly adding more and more partnerships with travel service agencies and other types of third-party service providers. This will help merchants deliver enhanced experiences to their customers as they seize the growth opportunities in the global travel market.
More details on the new innovations unveiled today by Alipay:
- The first is the expanded partnership with Worldline, an existing acquirer for Alipay that will work with Alipay’s e-wallet partners from Asia for the first time, allowing European merchants to accept payments from them through their Alipay-enabled points of sale. This multi-wallet acceptance means merchants across Europe will be able to drive increased footfall and spending from tourists from across Asia.
-
Additionally, Alipay has developed mini programs to enhance tourists’ experience at airports around the world, offering services such as convenient payments and personalized recommendations. Alipay Mini Programs officially launched in July 2018, opening up the service to independent programmers and enterprises to create interesting and useful “lite apps”.
- How it works: The first airport mini program was launched by Hong Kong International Airport, allowing orders to be fulfilled as quickly as 90 minutes from ordering, so travellers can shop online and buy at their leisure, well before they reach the airport, and pick up their duty-free purchases as soon as they arrive.
- Additional features: The tailor-made airport mini program provides a range of services including flight information, transfer and entry tips, and other practical features including an instant chat within the mini program. It is also embedded with Alipay’s scenario solutions such as online transportation reservation and scan to order dining, as well as reminders of estimated time through security and boarding notices just by inputting flight details. Users can also receive electronic coupons and membership benefits offered by Alipay, as well as one-stop information and optimised route recommendations in the airport, allowing them to enjoy the airport’s services with ease.
About Alipay
Operated by Ant Financial Services Group, Alipay is the world’s leading payment and lifestyle platform. Launched in 2004, Alipay serves over 1.2 billion users with its local e-wallets partners as of June 2019. Over the years, Alipay has evolved from a digital wallet to a lifestyle enabler. Users can hail a taxi, book a hotel, buy movie tickets, pay utility bills, make appointments with doctors, or purchase wealth management products directly from within the app. In addition to online payments, Alipay is expanding to in-store offline payments both inside and outside of China. Alipay’s in-store payment service covers over 50 markets across the world, and tax reimbursement via Alipay is supported in 35 markets. Alipay works with over 250 overseas financial institutions and payment solution providers to enable cross-border payments for Chinese travelling overseas and overseas customers who purchase products from Chinese e-commerce sites. Alipay currently supports 27 currencies.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191114005332/en/
Contact information
Media Inquiries
Yang Xinyun
Ant Financial
+8613816896301
xinyun.yang@antfin.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
